Mehmet DEMİR, Çetin Akpolat, Ceylan USLU, Gürcan Dogukan ARSLAN, Dilek GÜVEN

The analysis of optical coherence tomography angiographic parameters in patients with and without clinically significant diabetic macular edema

The aim of our study was to compare the parameters of optical coherence tomography angiography between eyes with clinically significant macular edema (CSME) and without (w/o) CSME in patients diagnosed with diabetic macular edema (DME). Sixty-eight eyes of 34 patients with DME were included in the cross-sectionally designed study. The eyes of the patients with DME were divided into 2 groups, including the eyes with CSME and the eyes w/o CSME. Optical coherence tomography (OCTA) parameters, including central macular thickness, superficial and deep capillary plexus, and choriocapillaris flow area were evaluated between these two groups. Eyes with CSME had a thicker central retinal thickness (CRT), (P≤0.001) and worse visual acuity (VA), (P=0.002), and there was a strong negative correlation between CRT and VA among patients with CSME (r=-0.616, P≤0.001). We observed increases in the vessel density (VD) measurements of the superficial fovea (P=0.006) and deep fovea areas (P=0.036), whereas reductions in the VD measurements of other deeper plexuses in the comparison of eyes with CSME and w/o CSME in patients with diagnosis of DME. We did not note significant differences between FAZ metrics. OCTA could be used as a noninvasive modality to assess and compare the structural and vasculature changes in diabetic patients with or/and w/o CSME.

PDF

___

1. Habib SL, Rojna M. Diabetes and risk of cancer. ISRN Oncol. 2013;2013:583786.

2. Cebeci Z, Kir N. Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant. Diabetes Metab Syndr Obes. 2015;8:555–66.

3. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12:346–54.

4. Lang GE. Diabetic macular edema. Ophthalmologica. 2012;227:21–9.

5. Ding J, Wont TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12:346–54.

6. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopa¬thy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17.

7. Executive Summary. IFD Diabetes Atlas. 7th edition. 2017;23-26.

8. Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema. Dev Ophthalmol. 2016;55:137-46.

9. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-36.

10. Campos PR, Rubio SC, García GDM, et al. Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice. Clin Ophthalmol. 2018;12:99-104.

11. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178–81.

12. Virgili G, Menchini F, Casazza G, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD008081.

13. de Carlo TE, Romano A, Waheed NK, et al. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous. 2015;1:5.

14. Soares M, Neves C, Marques IP, et al. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. 2017;101:62–8.

15. Khan HA, Mehmood A, Khan QA, et al. A major review of optical coherence tomography angiography. Expert Rev Ophthalmol. 2017;12:373–85.

16. Guo Y, Camino A, Wang J, et al. A neural network for automated detection of avascular area in OCT angiography. Biomed Opt Express. 2018;9:5147-58.

17. Khadamy J, Abri Aghdam K, Falavarjani KG. An update on optical coherence tomography angiography in diabetic retinopathy. J Ophthalmic Vis Res. 2018;13:487-97.

18. Mathew C, Yunirakasiwi A, Sanjay S. Updates in the management of diabetic macular edema. J Diabetes Res. 2015;2015:794036.

19. Simonett JM, Scarinci F, Picconi F, et al. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus. Acta Ophthalmol. 2017;95:e751-5.

20. Chun LY, Silas MR, Dimitroyannis RC, et al. Differences in macular capillary parameters between healthy black and white subjects with Optical Coherence Tomography Angiography (OCTA). PLoS One. 2019;14:e0223142.

21. Durbin MK, An L, Shemonski ND, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol. 2017;135:370-6.

22. Agemy SA, Scripsema NK, Shah CM, et al. Retinal vascular perfusion density mapping using optical coherence tomography angiography in normals and diabetic retinopathy patients. Retina. 2015; 35:2353–63.

23. Zhang M, Hwang TS, Dongye C, et al. Automated quantification of nonperfusion in three retinal plexuses using projection-resolved optical coherence tomography angiography in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57:5101–6.

24. Samara WA, Shahlaee A, Adam MK, et al. Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity. Ophthalmology. 2017;124:235–44.

25. Murakami T, Nishijima K, Sakamoto A, et al. Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. Am J Ophthalmol. 2011;151:310-7.

26. Islam F. Retinal thickness and visual acuity in diabetic macular edema: an optical coherence tomography-based study. J Coll Physicians Surg Pak. 2016;26:598-601.

27. Rangaraju L, Jiang X, McAnany JJ, et al. Association between visual acuity and retinal layer metrics in diabetics with and without macular edema. J Ophthalmol. 2018;2018:1089043.

28. Mo S, Krawitz B, Efstathiadis E, et al. Imaging foveal microvasculature: optical coherence tomography angiography versus adaptive optics scanning light ophthalmoscope fluorescein angiography. Invest Ophthalmol Vis Sci. 2016;57:130-40.

29. Sorour O, Arya M, Waheed N. New findings and challenges in OCT angiography for diabetic retinopathy. Ann Eye Sci. 2018;3:44.

30. Moein HR, Novais EA, Rebhun CB, et al. Optical coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema. Retina. 2018;38:2277-84.

31. Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015; 35:2377–83.

32. 32. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina. 2010;30:774-80.

33. Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525-36.

34. Goker Y, Tekin Kemal, Kiziltprak H, et al. Choriocapillaries signal voids in patients with diabetic retinopathy. Turkiye Klinikleri J Ophthalmol. 2019;28:43-51.

35. Choi W, Waheed NK, Moult EM, et al. Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina. 2017;37:11–21.

36. Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004; 88:1060–3.

37. Conti FF, Qin VL, Rodrigues EB, et al. Choriocapillaris and retinal vascular plexus density of diabetic eyes using split-spectrum amplitude decorrelation spectral-domain optical coherence tomography angiography. Br J Ophthalmol. 2019;103:452-6.

38. Yang J, Wang E, Zhao X, et al. Optical coherence tomography angiography analysis of the choriocapillary layer in treatment-naïve diabetic eyes. Graefes Arch Clin Exp Ophthalmol. 2019;257:1393-9.